Use of novel oral anticoagulants in patients with end-stage renal disease

被引：5
|
作者：
Winkelmayer, Wolfgang C. [1 ,2 ]
Herzog, Charles A. [3 ]
Montez-Rath, Maria E. [2 ]
Chang, Tara I. [2 ]
Chertow, Glenn M. [2 ]
机构：
[1] Baylor Coll Med, Nephrol Sect, Houston, TX 77030 USA
[2] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA
[3] Univ Minnesota, Hennepin Cty Med Ctr, Div Cardiol, Minneapolis, MN 55415 USA
来源：
HEMODIALYSIS INTERNATIONAL | 2015年 / 19卷 / 01期
关键词：
D O I：
10.1111/hdi.12251
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：150 / 153
页数：4
相关论文
共 50 条
  • [1] Direct Oral Anticoagulants in End-Stage Renal Disease
    Klil-Drori, Adi J.
    Tagalakis, Vicky
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2018, 44 (04): : 353 - 363
  • [2] Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Zaman, Junaid A. B.
    Bhandari, Anil K.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (06) : 499 - 508
  • [3] Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease
    Brimble, K. Scott
    Ingram, Alistair J.
    Eikelboom, John W.
    Hart, Robert G.
    [J]. POSTGRADUATE MEDICINE, 2012, 124 (06) : 17 - 25
  • [4] A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease
    Starr, Jessica A.
    Pinner, Nathan A.
    Mannis, Melanie
    Stuart, Mary Katherine
    [J]. ANNALS OF PHARMACOTHERAPY, 2022, 56 (06) : 691 - 703
  • [5] Bleeding Outcomes Using Novel Oral Anticoagulants (NOACs) in End-Stage Renal Disease (ESRD) Versus Coumadin
    Kalathil, Sheila Ann
    Jorge, Vinicius Machado
    Pakos, Irene
    Haydar, Ali
    Barnes, Drew
    Lo, Kevin
    Dourado, Claudia
    [J]. BLOOD, 2021, 138 : 1953 - +
  • [6] Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis
    Roh, Jae-Hyung
    Kim, Yong-Giun
    Kim, Doyeon
    Park, Sangwoo
    Park, Kyung Sun
    Kim, Minsu
    Hwang, Ki Won
    Hwang, Wonmook
    Park, Gyung-Min
    Lee, Jae-Hwan
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Nishimura, Marin
    Hsu, Jonathan C.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (01): : 131 - 140
  • [8] Oral health in patients with end-stage renal disease: A scoping review
    Laheij, Alexa
    Rooijers, Wietse
    Bidar, Lela
    Haidari, Lema
    Neradova, Aegida
    De Vries, Ralph
    Rozema, Frederik
    [J]. CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2022, 8 (01): : 54 - 67
  • [9] The Difficult Balance of Oral Anticoagulation in Patients With End-Stage Renal Disease
    Ilyas, Irtqa
    Doshi, Rajkumar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 350 - 351
  • [10] Use of regadenoson in end-stage renal disease
    Iskandrian, Ami E.
    Hage, Fadi G.
    Heo, Jaekyeong
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2013, 20 (02) : 182 - 184
12345